Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Sepracor's levalbuterol NDA accepted by FDA

Sep. 4, 1997

LT antagonist/antihistamine combination highly effective against EAR/LAR

Sep. 3, 1997

ET antagonists for asthma

Sep. 2, 1997

Anti-IgE antibody inhibits allergen-induced EAR

Sep. 2, 1997

North American clinical trials with LiquiVent to be reinitiated

Sep. 1, 1997

P&U cephem derivatives for inhibiting HLE

Aug. 29, 1997

FDA approves Hi-Tech's generic promethazine/codeine syrup

Aug. 28, 1997

Hoechst Marion Roussel reports new antiallergy agents

Aug. 25, 1997

New antiallergy agents described by Dainippon Ink

Aug. 20, 1997

Tachykinin antagonist with potential as antiasthmatic

Aug. 19, 1997

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...